Skip to main content
Label
Case Study

COVID-19 Registry for Oncology Patients Case Study

This study sought to monitor COVID-19 prevalence and course of symptoms among oncology patients in order to identify any correlations with the biological and clinical data collected from the oncology cohort.

Oncology
Infectious Disease
Download the PDF

Challenge

Hospital St. Joseph sought to better understand COVID-19 incidence and course of symptoms among oncology patients. They faced an acute study design challenge: how to gather high-quality data from patients with Stage III or IV cancers undergoing chemotherapy without overburdening them.

‍

‍

‍Solution

  • ObvioHealth designed a fully virtual observational study, where outcomes reporting using our app took, on average, less than 2 minutes a day.
  • Reminder notifications were automatically configured within the app to guide responses on COVID-19 incidence, symptom progression and resolution, as well as changes to medication.
  • Participants communicated with our virtual site team directly via the app’s chat feature, fostering closer communication and care.

‍

Study Design

  • Fully Virtual
  • BYOD ePRO
  • Remote Patient Monitoring
  • Virtual Site Team (COACH)

‍

Results

Patients were reported to be cautious and to follow all HCP recommendations: Mask wearing, hand washing, use of sanitizer, and social distancing (excluding clinic visits). No patients were diagnosed with COVID-19 during the study.  

Although 4 patients reported suspicious symptoms, all PCR tests returned negative, demonstrating the symptoms as non-COVID-19 related.

Patients reported that the Obvio-19 application was easy to use. Outcomes reporting took, on average, less than 2 minutes a day.

‍

‍

Conclusions

The ease with which the study participants interacted with the Obvio-19 app, and the success of the study design overall, is reflected in the feedback provided by several patients. These participants requested that the study duration be extended an additional 6 months, citing the daily questionnaire as a source of comfort, as well as concerns that there would be no one they could alert, if necessary, following the study’s completion.

Such participant satisfaction—in combination with high compliance and retention rates—indicate decentralized models including intuitive digital instruments might represent an effective avenue for conducting studies amongst oncology patients receiving at-home care. Study design could be adapted to meet these patients’ needs, requiring them to visit the clinics less frequently while also ensuring their compliance with tasks and medications and their safety through remote monitoring and the tracking of secondary effects.

Case Study

COVID-19 Registry for Oncology Patients Case Study

Oncology
Infectious Disease
This study sought to monitor COVID-19 prevalence and course of symptoms among oncology patients in order to identify any correlations with the biological and clinical data collected from the oncology cohort.
Download the PDF

Challenge

Hospital St. Joseph sought to better understand COVID-19 incidence and course of symptoms among oncology patients. They faced an acute study design challenge: how to gather high-quality data from patients with Stage III or IV cancers undergoing chemotherapy without overburdening them.

‍

‍

‍Solution

  • ObvioHealth designed a fully virtual observational study, where outcomes reporting using our app took, on average, less than 2 minutes a day.
  • Reminder notifications were automatically configured within the app to guide responses on COVID-19 incidence, symptom progression and resolution, as well as changes to medication.
  • Participants communicated with our virtual site team directly via the app’s chat feature, fostering closer communication and care.

‍

Study Design

  • Fully Virtual
  • BYOD ePRO
  • Remote Patient Monitoring
  • Virtual Site Team (COACH)

‍

Results

Patients were reported to be cautious and to follow all HCP recommendations: Mask wearing, hand washing, use of sanitizer, and social distancing (excluding clinic visits). No patients were diagnosed with COVID-19 during the study.  

Although 4 patients reported suspicious symptoms, all PCR tests returned negative, demonstrating the symptoms as non-COVID-19 related.

Patients reported that the Obvio-19 application was easy to use. Outcomes reporting took, on average, less than 2 minutes a day.

‍

‍

Conclusions

The ease with which the study participants interacted with the Obvio-19 app, and the success of the study design overall, is reflected in the feedback provided by several patients. These participants requested that the study duration be extended an additional 6 months, citing the daily questionnaire as a source of comfort, as well as concerns that there would be no one they could alert, if necessary, following the study’s completion.

Such participant satisfaction—in combination with high compliance and retention rates—indicate decentralized models including intuitive digital instruments might represent an effective avenue for conducting studies amongst oncology patients receiving at-home care. Study design could be adapted to meet these patients’ needs, requiring them to visit the clinics less frequently while also ensuring their compliance with tasks and medications and their safety through remote monitoring and the tracking of secondary effects.

Case Study

COVID-19 Registry for Oncology Patients Case Study

This study sought to monitor COVID-19 prevalence and course of symptoms among oncology patients in order to identify any correlations with the biological and clinical data collected from the oncology cohort.

Oncology
Infectious Disease
Download the PDF

Challenge

Hospital St. Joseph sought to better understand COVID-19 incidence and course of symptoms among oncology patients. They faced an acute study design challenge: how to gather high-quality data from patients with Stage III or IV cancers undergoing chemotherapy without overburdening them.

‍

‍

‍Solution

  • ObvioHealth designed a fully virtual observational study, where outcomes reporting using our app took, on average, less than 2 minutes a day.
  • Reminder notifications were automatically configured within the app to guide responses on COVID-19 incidence, symptom progression and resolution, as well as changes to medication.
  • Participants communicated with our virtual site team directly via the app’s chat feature, fostering closer communication and care.

‍

Study Design

  • Fully Virtual
  • BYOD ePRO
  • Remote Patient Monitoring
  • Virtual Site Team (COACH)

‍

Results

Patients were reported to be cautious and to follow all HCP recommendations: Mask wearing, hand washing, use of sanitizer, and social distancing (excluding clinic visits). No patients were diagnosed with COVID-19 during the study.  

Although 4 patients reported suspicious symptoms, all PCR tests returned negative, demonstrating the symptoms as non-COVID-19 related.

Patients reported that the Obvio-19 application was easy to use. Outcomes reporting took, on average, less than 2 minutes a day.

‍

‍

Conclusions

The ease with which the study participants interacted with the Obvio-19 app, and the success of the study design overall, is reflected in the feedback provided by several patients. These participants requested that the study duration be extended an additional 6 months, citing the daily questionnaire as a source of comfort, as well as concerns that there would be no one they could alert, if necessary, following the study’s completion.

Such participant satisfaction—in combination with high compliance and retention rates—indicate decentralized models including intuitive digital instruments might represent an effective avenue for conducting studies amongst oncology patients receiving at-home care. Study design could be adapted to meet these patients’ needs, requiring them to visit the clinics less frequently while also ensuring their compliance with tasks and medications and their safety through remote monitoring and the tracking of secondary effects.

Case Study

COVID-19 Registry for Oncology Patients Case Study

Oncology
Infectious Disease
Download the PDF

Challenge

Hospital St. Joseph sought to better understand COVID-19 incidence and course of symptoms among oncology patients. They faced an acute study design challenge: how to gather high-quality data from patients with Stage III or IV cancers undergoing chemotherapy without overburdening them.

‍

‍

‍Solution

  • ObvioHealth designed a fully virtual observational study, where outcomes reporting using our app took, on average, less than 2 minutes a day.
  • Reminder notifications were automatically configured within the app to guide responses on COVID-19 incidence, symptom progression and resolution, as well as changes to medication.
  • Participants communicated with our virtual site team directly via the app’s chat feature, fostering closer communication and care.

‍

Study Design

  • Fully Virtual
  • BYOD ePRO
  • Remote Patient Monitoring
  • Virtual Site Team (COACH)

‍

Results

Patients were reported to be cautious and to follow all HCP recommendations: Mask wearing, hand washing, use of sanitizer, and social distancing (excluding clinic visits). No patients were diagnosed with COVID-19 during the study.  

Although 4 patients reported suspicious symptoms, all PCR tests returned negative, demonstrating the symptoms as non-COVID-19 related.

Patients reported that the Obvio-19 application was easy to use. Outcomes reporting took, on average, less than 2 minutes a day.

‍

‍

Conclusions

The ease with which the study participants interacted with the Obvio-19 app, and the success of the study design overall, is reflected in the feedback provided by several patients. These participants requested that the study duration be extended an additional 6 months, citing the daily questionnaire as a source of comfort, as well as concerns that there would be no one they could alert, if necessary, following the study’s completion.

Such participant satisfaction—in combination with high compliance and retention rates—indicate decentralized models including intuitive digital instruments might represent an effective avenue for conducting studies amongst oncology patients receiving at-home care. Study design could be adapted to meet these patients’ needs, requiring them to visit the clinics less frequently while also ensuring their compliance with tasks and medications and their safety through remote monitoring and the tracking of secondary effects.

Case Study

COVID-19 Registry for Oncology Patients Case Study

Oncology
Infectious Disease
Download the PDF

Challenge

Hospital St. Joseph sought to better understand COVID-19 incidence and course of symptoms among oncology patients. They faced an acute study design challenge: how to gather high-quality data from patients with Stage III or IV cancers undergoing chemotherapy without overburdening them.

‍

‍

‍Solution

  • ObvioHealth designed a fully virtual observational study, where outcomes reporting using our app took, on average, less than 2 minutes a day.
  • Reminder notifications were automatically configured within the app to guide responses on COVID-19 incidence, symptom progression and resolution, as well as changes to medication.
  • Participants communicated with our virtual site team directly via the app’s chat feature, fostering closer communication and care.

‍

Study Design

  • Fully Virtual
  • BYOD ePRO
  • Remote Patient Monitoring
  • Virtual Site Team (COACH)

‍

Results

Patients were reported to be cautious and to follow all HCP recommendations: Mask wearing, hand washing, use of sanitizer, and social distancing (excluding clinic visits). No patients were diagnosed with COVID-19 during the study.  

Although 4 patients reported suspicious symptoms, all PCR tests returned negative, demonstrating the symptoms as non-COVID-19 related.

Patients reported that the Obvio-19 application was easy to use. Outcomes reporting took, on average, less than 2 minutes a day.

‍

‍

Conclusions

The ease with which the study participants interacted with the Obvio-19 app, and the success of the study design overall, is reflected in the feedback provided by several patients. These participants requested that the study duration be extended an additional 6 months, citing the daily questionnaire as a source of comfort, as well as concerns that there would be no one they could alert, if necessary, following the study’s completion.

Such participant satisfaction—in combination with high compliance and retention rates—indicate decentralized models including intuitive digital instruments might represent an effective avenue for conducting studies amongst oncology patients receiving at-home care. Study design could be adapted to meet these patients’ needs, requiring them to visit the clinics less frequently while also ensuring their compliance with tasks and medications and their safety through remote monitoring and the tracking of secondary effects.

Case Study

COVID-19 Registry for Oncology Patients Case Study

This study sought to monitor COVID-19 prevalence and course of symptoms among oncology patients in order to identify any correlations with the biological and clinical data collected from the oncology cohort.

Download the PDF
Oncology
Infectious Disease

Challenge

Hospital St. Joseph sought to better understand COVID-19 incidence and course of symptoms among oncology patients. They faced an acute study design challenge: how to gather high-quality data from patients with Stage III or IV cancers undergoing chemotherapy without overburdening them.

‍

‍

‍Solution

  • ObvioHealth designed a fully virtual observational study, where outcomes reporting using our app took, on average, less than 2 minutes a day.
  • Reminder notifications were automatically configured within the app to guide responses on COVID-19 incidence, symptom progression and resolution, as well as changes to medication.
  • Participants communicated with our virtual site team directly via the app’s chat feature, fostering closer communication and care.

‍

Study Design

  • Fully Virtual
  • BYOD ePRO
  • Remote Patient Monitoring
  • Virtual Site Team (COACH)

‍

Results

Patients were reported to be cautious and to follow all HCP recommendations: Mask wearing, hand washing, use of sanitizer, and social distancing (excluding clinic visits). No patients were diagnosed with COVID-19 during the study.  

Although 4 patients reported suspicious symptoms, all PCR tests returned negative, demonstrating the symptoms as non-COVID-19 related.

Patients reported that the Obvio-19 application was easy to use. Outcomes reporting took, on average, less than 2 minutes a day.

‍

‍

Conclusions

The ease with which the study participants interacted with the Obvio-19 app, and the success of the study design overall, is reflected in the feedback provided by several patients. These participants requested that the study duration be extended an additional 6 months, citing the daily questionnaire as a source of comfort, as well as concerns that there would be no one they could alert, if necessary, following the study’s completion.

Such participant satisfaction—in combination with high compliance and retention rates—indicate decentralized models including intuitive digital instruments might represent an effective avenue for conducting studies amongst oncology patients receiving at-home care. Study design could be adapted to meet these patients’ needs, requiring them to visit the clinics less frequently while also ensuring their compliance with tasks and medications and their safety through remote monitoring and the tracking of secondary effects.

Back to Top
Case Study

COVID-19 Registry for Oncology Patients Case Study

This study sought to monitor COVID-19 prevalence and course of symptoms among oncology patients in order to identify any correlations with the biological and clinical data collected from the oncology cohort.

Oncology
Infectious Disease
Download the PDF

Challenge

Hospital St. Joseph sought to better understand COVID-19 incidence and course of symptoms among oncology patients. They faced an acute study design challenge: how to gather high-quality data from patients with Stage III or IV cancers undergoing chemotherapy without overburdening them.

‍

‍

‍Solution

  • ObvioHealth designed a fully virtual observational study, where outcomes reporting using our app took, on average, less than 2 minutes a day.
  • Reminder notifications were automatically configured within the app to guide responses on COVID-19 incidence, symptom progression and resolution, as well as changes to medication.
  • Participants communicated with our virtual site team directly via the app’s chat feature, fostering closer communication and care.

‍

Study Design

  • Fully Virtual
  • BYOD ePRO
  • Remote Patient Monitoring
  • Virtual Site Team (COACH)

‍

Results

Patients were reported to be cautious and to follow all HCP recommendations: Mask wearing, hand washing, use of sanitizer, and social distancing (excluding clinic visits). No patients were diagnosed with COVID-19 during the study.  

Although 4 patients reported suspicious symptoms, all PCR tests returned negative, demonstrating the symptoms as non-COVID-19 related.

Patients reported that the Obvio-19 application was easy to use. Outcomes reporting took, on average, less than 2 minutes a day.

‍

‍

Conclusions

The ease with which the study participants interacted with the Obvio-19 app, and the success of the study design overall, is reflected in the feedback provided by several patients. These participants requested that the study duration be extended an additional 6 months, citing the daily questionnaire as a source of comfort, as well as concerns that there would be no one they could alert, if necessary, following the study’s completion.

Such participant satisfaction—in combination with high compliance and retention rates—indicate decentralized models including intuitive digital instruments might represent an effective avenue for conducting studies amongst oncology patients receiving at-home care. Study design could be adapted to meet these patients’ needs, requiring them to visit the clinics less frequently while also ensuring their compliance with tasks and medications and their safety through remote monitoring and the tracking of secondary effects.

Discover More Case Studies

Discover More News

Discover More White Papers

Discover More Blogs

Discover More Playbooks

Discover More Webinars

Discover More Events

Infectious Disease

Norovirus Vaccine Study​

VaxArt needed solutions for evaluating the safety and immunogenicity of its orally administered norovirus vaccine. Of particular importance was incorporating a way to quickly detect severe reactogenicity symptoms during the first week following vaccine administration. ​

› Read More
CNS

Sub-Clinical Mood Disorders

A government agency is aiming to identify digital biomarkers of depressive and anxious feelings. The agency needed to capture both objective and subjective data for analysis.

› Read More